Artificial intelligence is making transformative impacts in clinical decision-making for oncology and cardiology. Studies show AI-based models personalizing cancer treatment protocols, including immune profiling for tumor characterization and AI-enhanced CT scans measuring coronary inflammation to predict heart attack risk. These innovations promise earlier and more precise interventions, potentially improving patient outcomes and healthcare efficiency.<BR><BR>Regulatory bodies have begun to endorse AI tools, signaling a growing acceptance and integration of computational methodologies in disease diagnosis and management.